{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:11:21Z","timestamp":1793247081049,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.amjcard.2023.10.064","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T07:54:37Z","timestamp":1706601277000},"page":"S42-S52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"S","title":["Treatment Strategies for Hypertrophic Cardiomyopathy: Alcohol Septal Ablation and Procedural Step-by-Step Technique"],"prefix":"10.1016","volume":"212","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9962-2376","authenticated-orcid":false,"given":"Atul D.","family":"Bali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaqib","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srihari S.","family":"Naidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2023.10.064_bib0001","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.3390\/jcm10112276","article-title":"Alcohol septal ablation: an option on the rise in hypertrophic obstructive cardiomyopathy","volume":"10","author":"Ar\u00e9valos","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0002","first-page":"e558","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of PatientsWith hypertrophic cardiomyopathy: A report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.amjcard.2023.10.064_bib0003","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/biom9120878","article-title":"Hypertrophic cardiomyopathy: an overview of genetics and management","volume":"9","author":"Teekakirikul","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0004","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jacc.2022.10.027","article-title":"Survival after septal reduction in patients >65 years old with obstructive hypertrophic cardiomyopathy","volume":"81","author":"Mentias","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0005","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/jamacardio.2023.3342","article-title":"Mavacamten in patients with hypertrophic cardiomyopathy referred for septal reduction: Week 56 results from the VALOR-HCM randomized clinical trial","volume":"8","author":"Desai","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0006","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/CIRCULATIONAHA.120.052359","article-title":"Mavacamten favorably impacts cardiac structure in obstructive hypertrophic cardiomyopathy: EXPLORER-HCM cardiac magnetic resonance substudy analysis","volume":"143","author":"Saberi","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0007","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11886-021-01508-0","article-title":"Mavacamten, a novel therapeutic strategy for obstructive hypertrophic cardiomyopathy","volume":"23","author":"Zampieri","year":"2021","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0008","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/S0140-6736(21)00763-7","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"397","author":"Spertus","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0009","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jacc.2022.04.048","article-title":"Myosin inhibition in patients with obstructive hypertrophic cardiomyopathy referred for septal reduction therapy","volume":"80","author":"Desai","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0010","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1016\/S0140-6736(21)01205-8","article-title":"Hypertrophic cardiomyopathy: a practical approach to guideline directed management","volume":"398","author":"Ommen","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0011","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jamacardio.2016.0252","article-title":"Hospital volume outcomes after septal myectomy and alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: US nationwide inpatient database, 2003\u20132011","volume":"1","author":"Kim","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0012","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.athoracsur.2022.05.062","article-title":"Impact of hospital volume on outcomes of septal myectomy for hypertrophic cardiomyopathy","volume":"114","author":"Holst","year":"2022","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0013","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.jacc.2015.06.1333","article-title":"Low operative mortality achieved with surgical septal myectomy: role of dedicated hypertrophic cardiomyopathy centers in the management of dynamic subaortic obstruction","volume":"66","author":"Maron","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0014","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028693","article-title":"Hospital procedural volume and clinical outcomes following septal reduction therapy in obstructive hypertrophic cardiomyopathy","volume":"12","author":"Altibi","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0015","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/ehf2.14272","article-title":"Alcohol septal ablation in hypertrophic cardiomyopathy: for which patients?","volume":"10","author":"Achim","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0016","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amjcard.2014.11.030","article-title":"Biventricular reverse remodeling after successful alcohol septal ablation for obstructive hypertrophic cardiomyopathy","volume":"115","author":"Chen","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0017","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.21669","article-title":"Association of hypertrophic obstructive cardiomyopathy with outcomes following transcatheter aortic valve replacement","volume":"3","author":"Bandyopadhyay","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0018","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018435","article-title":"Outcomes in patients with obstructive hypertrophic cardiomyopathy and concomitant aortic stenosis undergoing surgical myectomy and aortic valve replacement","volume":"10","author":"Desai","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0019","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1161\/CIRCULATIONAHA.111.076257","article-title":"Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy","volume":"126","author":"Sorajja","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0020","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10840-018-0433-0","article-title":"The effects of septal myectomy and alcohol septal ablation for hypertrophic cardiomyopathy on the cardiac conduction system","volume":"52","author":"Fitzgerald","year":"2018","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0021","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1111\/jce.14679","article-title":"Cardiac implantable electronic device placement following alcohol septal ablation for hypertrophic cardiomyopathy in the United States","volume":"31","author":"Lam","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0022","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11936-023-01002-6","article-title":"State-of-the-art review: alcohol septal ablation in hypertrophic cardiomyopathy","volume":"25","author":"Bali","year":"2023","journal-title":"Curr Treat Options Cardio. Med"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0023","first-page":"436","article-title":"Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: novel application of the cutting balloon","volume":"18","author":"Polin","year":"2006","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0024","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1530\/ERP-15-0002","article-title":"Intra-cardiac echocardiography in alcohol septal ablation: a prospective comparative study against trans-thoracic echocardiography","volume":"2","author":"Cooper","year":"2015","journal-title":"Echo Res Pract"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0025","article-title":"Alcohol septal ablation or septal myectomy? An updated systematic review and meta-analysis of septal reduction therapy for hypertrophic obstructive cardiomyopathy","volume":"9","author":"Zheng","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0026","first-page":"245","article-title":"Alcohol septal ablation for obstructive hypertrophic cardiomyopathy","volume":"11","author":"Sorajja","year":"2022","journal-title":"Interv Cardiol Clin"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0027","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.jacc.2022.02.032","article-title":"Survival following alcohol septal ablation or septal myectomy for patients with obstructive hypertrophic cardiomyopathy","volume":"79","author":"Cui","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0028","doi-asserted-by":"crossref","first-page":"36","DOI":"10.21037\/cdt.2019.07.02","article-title":"Current state of the roles of alcohol septal ablation and surgical myectomy in the treatment of hypertrophic obstructive cardiomyopathy","volume":"10","author":"Douglas","year":"2020","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0029","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jcin.2020.10.002","article-title":"Sex differences in the outcomes of septal reduction therapies for obstructive hypertrophic cardiomyopathy","volume":"14","author":"Sreenivasan","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0030","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/eurheartj\/ehv693","article-title":"Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry","volume":"37","author":"Veselka","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0031","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1016\/j.jacc.2018.09.064","article-title":"Survival after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy","volume":"72","author":"Batzner","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0032","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ejhf.1715","article-title":"Hypertrophic cardiomyopathy: the future of treatment","volume":"22","author":"Tuohy","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0033","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/eurheartj\/ehz110","article-title":"Short- and long-term outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy in patients with mild left ventricular hypertrophy: a propensity score matching analysis","volume":"40","author":"Veselka","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0034","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jchf.2015.06.011","article-title":"A systematic review and meta-analysis of long-term outcomes after septal reduction therapy in patients with hypertrophic cardiomyopathy","volume":"3","author":"Liebregts","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.amjcard.2023.10.064_bib0035","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1055\/s-0038-1675213","article-title":"Results of ten-year follow-up of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy","volume":"27","author":"Kashtanov","year":"2018","journal-title":"Int J Angiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291492301233X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291492301233X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:51:55Z","timestamp":1757573515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000291492301233X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":35,"alternative-id":["S000291492301233X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.10.064","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment Strategies for Hypertrophic Cardiomyopathy: Alcohol Septal Ablation and Procedural Step-by-Step Technique","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.10.064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}